The Food and Drug Administration (FDA) has classified a batch of bread rolls produced by Jesse’s Bakery, Inc. in Honolulu, Hawaii, as Class I, following a recall in February due to undeclared milk.
This classification indicates that consuming the affected product may result in serious health consequences, including death.
For this story, Newsweek left a voicemail with Jesse’s Bakery.
Why It Matters
The products contained undeclared milk, one of the top nine allergens in the United States. According to the FDA, while most food allergies cause mild symptoms, some can progress to severe, life-threatening allergic reactions known as anaphylaxis.
It also stated that this can result in constricted airways in the lungs, severe blood pressure and shock, and suffocation due to swelling of the throat and larynx.
What to Know
The recall was prompted by the discovery of undeclared milk in the Pan de Sal product.
Allergic reactions to milk can range from minor symptoms, such as hives or gastrointestinal distress, to severe anaphylactic reactions requiring immediate medical attention.
Jesse’s Bakery, Inc. voluntarily initiated the recall on February 7, 2025, after conducting internal quality checks. On March 4, 2025, the FDA classified the recall as a Class I event, indicating the most serious concern for public health.
The recalled Pan de Sal comes in a 9-ounce flexible poly bag containing six rolls. The product label bears the branding of Jesse’s Bakery, Inc., as well as its Honolulu address and contact information.
The affected items have the UPC code 0 38511 00703 4 and may contain any of the following product codes: 26, 206, 27, 207, 28, 208, 29, 209, 210, 211, 212, 213, or 214.
The recall covers 97 Spanish roll packages, with distribution limited to Hawaii. The bakery has yet to issue a public press release regarding the recall.
What People Are Saying
According to the FDA website, the agency issues a Class I recall in “a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.”
What Happens Next
At time of writing, the FDA does not have a termination date scheduled for the recall to end.
